"Bacterial Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
| Descriptor ID |
D001428
|
| MeSH Number(s) |
D20.215.894.135
|
| Concept/Terms |
Bacterial Vaccines- Bacterial Vaccines
- Vaccine, Bacterial
- Bacterin
- Bacterial Vaccine
- Vaccines, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Bacterial Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Bacterial Vaccines".
This graph shows the total number of publications written about "Bacterial Vaccines" by people in this website by year, and whether "Bacterial Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bacterial Vaccines" by people in Profiles.
-
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink. Vaccine. 2023 07 19; 41(32):4658-4665.
-
Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med. 2014 Feb; 46(2):150-7.
-
New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009 Jun; 123(6):1452-63.
-
Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med. 2002 Feb 14; 346(7):491-6.
-
Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA. 2000 Mar 15; 283(11):1460-8.
-
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar; 19(3):187-95.
-
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999 Sep; 18(9):757-63.
-
Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis. 1992 Jun; 165 Suppl 1:S139-43.
-
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):97-104.
-
Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):92-6.